XML 80 R68.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue - Schedule of GTN Product Revenue, Net (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Gross To Net Sales Adjustment Rollforward [Roll Forward]          
Balance as of June 30, 2025 $ 14,182 $ 14,508 $ 17,489 $ 11,337  
GTN accruals for current period 5,188 6,487 17,167 18,608  
Prior period adjustments (780) (378) (1,553) (1,442)  
Credits, payments and reclassifications (3,810) (4,224) (18,323) (12,110)  
Balance as of September 30, 2025 14,780 16,393 14,780 16,393  
Gross To Net Sales Adjustment [Abstract]          
Accounts receivable, net 1,516   1,516   $ 1,792
Other current and non-current liabilities 13,264   13,264   15,697
Gross to net sales adjustment 14,780 16,393 14,780 16,393 17,489
Discarded Drug Rebate          
Gross To Net Sales Adjustment Rollforward [Roll Forward]          
Balance as of June 30, 2025 11,692 11,251 15,103 7,391  
GTN accruals for current period 1,547 2,051 5,516 5,955  
Prior period adjustments (545) 0 (745) (44)  
Credits, payments and reclassifications 0 0 (7,180) 0  
Balance as of September 30, 2025 12,694 13,302 12,694 13,302  
Gross To Net Sales Adjustment [Abstract]          
Gross to net sales adjustment 12,694 13,302 12,694 13,302 15,103
Other Adjustments          
Gross To Net Sales Adjustment Rollforward [Roll Forward]          
Balance as of June 30, 2025 2,490 3,257 2,386 3,946  
GTN accruals for current period 3,641 4,436 11,651 12,653  
Prior period adjustments (235) (378) (808) (1,398)  
Credits, payments and reclassifications (3,810) (4,224) (11,143) (12,110)  
Balance as of September 30, 2025 2,086 3,091 2,086 3,091  
Gross To Net Sales Adjustment [Abstract]          
Gross to net sales adjustment $ 2,086 $ 3,091 $ 2,086 $ 3,091 $ 2,386